Clinical Trial Update: A Study of the Safety and Efficacy of Pemetrexed Combined with Nivolumab Via Intraventricular Injection for the Treatment of Refractory Non-squamous Non-small Cell Lung Cancer with Leptomeningeal Metastases [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating intraventricular pemetrexed plus nivolumab for refractory non-squamous non-small cell lung cancer with leptomeningeal metastases; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leptomeningeal Metastasis
• Non-small Cell Lung Cancer

Drugs mentioned

• Pemetrexed (pemetrexed)
• nivolumab (nivolumab)

Snippet

Sponsor: Shanghai Cancer Hospital, China | Conditions: Leptomeningeal Metastasis | Phase 2 | Status: RECRUITING